EXEL
ExelixisCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
EXEL vs peer average
54/100
EXEL vs. peer average (C vs. C)
Grade spread
C 9 · D 1 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
GILD is the first available peer comparator.
Large-cap oncology and biopharma peer with broader diversification; useful for benchmarking commercial durability and pipeline optionality, but not a clean single-product oncology comp.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
EXEL
Exelixis
GILD
Gilead Sciences
Grade
C
C
Momentum
51
25
Value
65
65
Sentiment
33
52
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs GILD
EXEL / GILD
Grade Position
In line
EXEL vs. peer average (C vs. C)
54/100
Momentum
51
EXELValue
65
GILDSentiment
33
GILDRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs EXEL
GILD is the first peer returned for this comparison set.